Information processing suppression

Information processing suppression is a reduction in the mind's capacity to take in, integrate, and make sense of incoming information.

As a drug effect it is acute and dose-proportional, easing as the substance wears off, which distinguishes it from the cognitive deficits associated with neurological conditions. It ranges from a mild slowing of thought and difficulty tracking complex ideas to a near-complete inability to parse or respond to the environment.

It is among the more commonly reported cognitive effects across psychoactive substances. It is most commonly induced at moderate to high doses under psychedelics such as LSD and psilocybin mushrooms, and under depressants such as alcohol and flunitrazolam. It also appears in an overload-driven form under stimulants such as A-PHP and desoxypipradrol, and in a severe, disorganized form under deliriants such as datura.

Information processing suppression is felt as a narrowing of cognitive bandwidth: incoming information arrives but does not cohere, threads of thought lose connection before they resolve, and following a sentence or instruction requires noticeable effort. It commonly comes with mental heaviness, slowed reaction time, and difficulty retrieving words.

Attempting to push through it tends to compound the difficulty — effort accelerates the sense of overwhelm. At high doses, particularly under depressants and deliriants, it can shade into a state where the environment becomes largely unintelligible.

Information processing suppression arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, destabilizing predictive processing and flooding perception with signal that exceeds integrative capacity.
• Depressants — potentiate GABAergic inhibition, broadly slowing neural transmission and reducing the fidelity of signal integration across brain regions.
• Stimulants — at high doses, produce cognitive overload through excessive dopaminergic and noradrenergic activation, fragmenting rather than sharpening thought.
• Deliriants — block muscarinic acetylcholine receptors, disrupting the cholinergic systems central to attention and information integration.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses consistently raise both the likelihood and depth of suppression. It intensifies in cognitively demanding or unfamiliar settings — especially under psychedelics and deliriants — and in people with limited prior experience with a substance.

Expecting mental impairment can amplify it; going in apprehensive about losing cognitive clarity tends to make the experience more distressing. Familiarity with the substance, lower doses, and a calm, low-stimulus environment all reduce its severity.